INS and type 2 diabetes mellitus: Recent reports have reinforced the notion that in vivo stimulation of the AT2R with C21 leads to major beneficial actions, including reduction of inflammation [33], attenuation of cardiac fibrosis [34], antagonism of the thromboxane receptor [35], enhancement of insulin sensitivity and amelioration of type-2 diabetes complications [6,19,20].